CancerCare Manitoba Foundation
Winnipeg, MB R3E 0V9
President & CEO: Annitta Stenning
Board Chair: Janice Filmon
Charitable Reg. #: 88688 6746 RR0001
Grade: B+The grade is based on the charity's public reporting of the work it does and the results it achieves.
Need for Funding
Full-time staff #15
Avg. Compensation $84,838
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||0|
|$160k - $200k||1|
|$120k - $160k||1|
|$80k - $120k||2|
|$40k - $80k||6|
About CancerCare Manitoba Foundation:
Founded in 1997, the CancerCare Manitoba Foundation (CCMF) raises funds solely for CancerCare Manitoba (CCMB), a cancer research charity that also runs education and patient care programs to improve cancer diagnosis, treatment and prevention across Manitoba. All grants must pass a three-step process, where CCMF reviews the application for scientific and medical merit, ensures that finances are available, and finally sends the application to the Foundation Board for final approval. CCMF’s current annual report states that its grants went toward four major program areas in F2015.
Research, education and equipment grants made up 57% of CCMF’s granting activities in F2015, which included a major grant of $1.58m toward the CancerCare Manitoba’s Research Institute of Oncology and Hematology. CCMF reports that it funds 19 senior scientists, two PhD students, four Masters students, one undergraduate student and two lab technicians at the Institute.
Clinical trial grants made up 18% of CCMF’s granting activities in F2015. CCMF reports that it funded over 50% of the 59 pediatric clinical trials available for funding in the year. CCMF saw success when CancerCare Manitoba’s Blood and Marrow Transplant team was the first to save the lives of twin girls born with a fatal blood-clotting disease called alpha-thalassemia by performing in-utero blood transfusions followed by bone marrow transplants after birth.
Patient Support grants made up 15% of CCMF’s granting activities in F2015. The Foundation’s current Spring 2016 Foundation News report states that within the year, CancerCare Manitoba piloted its Subcutaneous Immunoglobin program that teaches patients with compromised immune systems how to self-administer their plasma infusion. 52 patients have completed the program since its launch and can now reduce their infusion time from 5-8 hours a month to 30 minutes a week, equivalent to 1,728 saved chair hours and one full-time nursing position.
Epidemiology grants made up 6% of granting activities in F2105, which went entirely to CancerCare Manitoba’s Department of Epidemiology and the Cancer Registry. The department studies cancer incidence patterns in Manitoba, hoping to uncover reasons behind cancer trends and information that can help with cancer prevention, early diagnosis and improved treatment.
CancerCare Manitoba Foundation is a Big-cap charity with total donations and special events revenues of $8.5m in F2015. Administrative costs are 10% of revenues and fundraising costs are 22% of donations. $0.32 of every donated dollar goes toward overhead costs, which falls Ci’s reasonable range for overhead spending.
The Foundation holds $49.6m in investments in F2015, of which 67% are held in equities. Investments grew by 9% in F2015 and 26% in F2014. Investment income of $5.4m in F2015, including unrealized gains of $2.4m and gross of investment management fees, represents a 12% return on investment. Investment income of $7.0m in F2014 earned a 19% return on investment.
The Foundation’s funding reserves total $49.7m in F2015, of which $13.4m are donor-endowed. Excluding CCMF’s endowment fund, funding reserves can cover granting activities for 6.8 years.
This charity report is an update that is currently being reviewed by CancerCare Manitoba Foundation. Changes and edits may be forthcoming.
Updated on July 18, 2016 by Katie Khodawandi.
Financial RatiosFiscal year ending March
|Administrative costs as % of revenues||8.9%||8.0%||8.3%|
|Fundraising costs as % of donations||22.2%||18.4%||21.0%|
|Program cost coverage (%)||828.0%||728.5%||633.7%|
Summary Financial StatementsAll figures in $000s
|Cash flow from operations||5,102||6,688||3,134|